EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Muscle‐specific Keap1 deletion enhances force production but does not prevent inactivity‐induced muscle atrophy in mice

Edwin R Miranda iD, Justin L Shahtout iD, Shinya Watanabe iD, Norah Milam, Takuya Karasawa iD, Subhasmita Rout iD, Donald L Atkinson iD, William L Holland iD, Micah J Drummond iD, Katsuhiko Funai iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202402810r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Edwin R Miranda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Muscular Atrophy, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Institute on Aging (NIA), NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immobilization‐associated muscle atrophy and weakness appear to be driven in part by oxidative stress. Nuclear Factor Erythroid 2‐Related Factor 2 (NRF2) is a critical redox rheostat that regulates oxidative stress responses, and its deletion is known to accelerate muscle atrophy and weakness during aging (sarcopenia) or denervation. Conversely, pharmacologic activation of NRF2 extends mouse lifespan and attenuates sarcopenia. Similarly, deletion of Kelch‐like ECH‐associated Protein 1 (Keap1), a negative regulator of NRF2, enhances exercise capacity. The purpose of this study was to determine whether muscle‐specific Keap1 deletion is sufficient to prevent muscle atrophy and weakness in mice following 7 days of hindlimb unloading (HU). To test this hypothesis, control (Ctrl) and tamoxifen‐inducible, muscle‐specific Keap1 knockout (mKO) mice were subjected to either normal housing (Sham) or HU for 7 days. Activation of NRF2 in muscle was confirmed by increased mRNA of NRF2 targets thioredoxin 1 (Txn1) and NAD(P)H quinone dehydrogenase 1 (NQO1) in mKO mice. Keap1 deletion had an effect to increase force‐generating capacity at baseline. However, muscle masses, cross‐sectional area, and ex vivo force were not different between mKO and Ctrl HU mice. In addition, muscle 4‐hydroxynonenal‐modified proteins and protein carbonyls were unaffected by Keap1 deletion. These data suggest that NRF2 activation improves muscle force production during ambulatory conditions but is not sufficient to prevent muscle atrophy or weakness following 7 days of HU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kelch-Like ECH-Associated Protein 1Muscular AtrophyMuscle, SkeletalAnimalsMiceMice, KnockoutNF-E2-Related Factor 2Hindlimb SuspensionMaleOxidative StressMice, Inbred C57BLNAD(P)H Dehydrogenase (Quinone)

Stichwörter der Autor:innen

NRF2carbonyl stressoxidative stressredoxsarcopenia

Substanzen

Kelch-Like ECH-Associated Protein 1Keap1 protein, mouseNF-E2-Related Factor 2Nfe2l2 protein, mouseNAD(P)H Dehydrogenase (Quinone)

Autor:innen und Institutionen

  • Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
  • Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
  • Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
  • Department of Physical Therapy & Athletic Training, University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Edwin R Miranda, Justin L Shahtout, Shinya Watanabe, Takuya Karasawa, Subhasmita Rout, Donald L Atkinson, William L Holland, Micah J Drummond, Katsuhiko Funai

Förderung

  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • HHS | NIH | National Institute on Aging (NIA)
  • NIA NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • HHS | NIH | NHLBI | Division of Intramural Research (DIR)
  • HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
  • NHLBI NIH HHS

Zitieren

APA

Miranda, E. R., Shahtout, J. L., Watanabe, S., Milam, N., Karasawa, T., Rout, S., Atkinson, D. L., Holland, W. L., Drummond, M. J., & Funai, K. (2025). Muscle‐specific Keap1 deletion enhances force production but does not prevent inactivity‐induced muscle atrophy in mice. The FASEB Journal. https://doi.org/10.1096/fj.202402810r

Vancouver

Miranda ER, Shahtout JL, Watanabe S, Milam N, Karasawa T, Rout S, et al. Muscle‐specific Keap1 deletion enhances force production but does not prevent inactivity‐induced muscle atrophy in mice. The FASEB Journal. 2025. doi:10.1096/fj.202402810r

BibTeX
@article{Miranda2025,
  author = {Miranda, Edwin R and Shahtout, Justin L and Watanabe, Shinya and Milam, Norah and Karasawa, Takuya and Rout, Subhasmita and Atkinson, Donald L and Holland, William L and Drummond, Micah J and Funai, Katsuhiko},
  title = {Muscle‐specific Keap1 deletion enhances force production but does not prevent inactivity‐induced muscle atrophy in mice},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202402810r}
}
Kostenlos starten →